Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
Purpose. To evaluate the effect of preoperative intravitreal conbercept (IVC) injection on patients with proliferative diabetic retinopathy (PDR). Methods. Medical records of patients who underwent vitrectomy due to complications of PDR were retrospectively reviewed. Patients were grouped as the IVC...
Main Authors: | Wei Xu, Weijing Cheng, Yao Yao, Jian Guo, Guoxing Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2019/2923950 |
Similar Items
-
Effects of vitrectomy with preoperative intravitreal Conbercept for proliferative diabetic retinopathy
by: Huai-Sheng Zhou, et al.
Published: (2018-02-01) -
Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
by: Jian-Bo Mao, et al.
Published: (2018-07-01) -
Clinical study of Conbercept in patients with proliferative diabetic retinopathy undergoing vitrectomy
by: Shao-Hua Shi, et al.
Published: (2020-05-01) -
Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01) -
Clinical effect of 25G+ vitrectomy combined with intravitreal injection of Conbercept in the treatment of severe proliferative diabetic retinopathy
by: Yong-Mou Zhou, et al.
Published: (2017-12-01)